About Divakar
Divakar Gupta is a partner at Cooley LLP, specializing in capital markets, particularly within the biopharmaceutical sector. He is admitted to practice law in Texas, California, and New York, with an active status in all jurisdictions.
Gupta earned his Juris Doctor (J.D.) from Harvard Law School in 2000, graduating cum laude. Prior to that, he obtained a Bachelor of Science (B.S.) in Chemistry from Yale University in 1997, where he graduated magna cum laude and was elected to Phi Beta Kappa.
His practice areas include representing public and private emerging growth companies and investment banking firms. Gupta's expertise encompasses public offerings of equity, high-yield debt, and convertible debt, as well as venture capital financings and mergers and acquisitions. He has significant experience advising on securities and general corporate matters across various industries, including life sciences, technology, healthcare, REITs, energy, and retail.
Gupta joined Cooley LLP as a partner in the business department's capital markets practice group in New York on March 10, 2014, after serving as a partner at Latham & Watkins LLP. His legal practice involves various stages, including negotiations and public offerings, although specific details regarding hearings, appeals, litigation, or trials are not publicly disclosed.
In 2015, Gupta was recognized as a capital markets "Rising Star" by Law360 for his contributions to complex deals in the life sciences and technology sectors. He is actively involved in the legal community and maintains his professional associations.
